Contrast-enhanced CT quantification of the hepatic fractional extracellular space: Correlation with diffuse liver disease severity

Maurice H. Zissen, Zhen Jane Wang, Judy Yee, Rizwan Aslam, Alexander Monto, Benjamin M. Yeh

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

OBJECTIVE. The purpose of this study was to determine whether contrast-enhanced CT quantification of the hepatic fractional extracellular space (ECS) correlates with the severity of diffuse liver disease. MATERIALS AND METHODS. The cases of 70 patients without (46 men, 24 women; mean age, 59.1 years) and 36 patients with (23 men, 13 women; mean age, 63.1 years) cirrhosis who had undergone unenhanced and 10-minute delayed phase contrast-enhanced CT were retrospectively identified. By consensus one experienced radiologist and one trainee measured the CT attenuation of the liver and aorta to estimate the fractional ECS, defined as the ratio of the difference between the attenuation of the liver on 10-minute and unenhanced images to the difference between the attenuation of the aorta on 10-minute and unenhanced images multiplied by 1 minus the hematocrit. Findings were correlated with each patient's Model of End-Stage Liver Disease (MELD) score. RESULTS. The mean MELD score was higher in patients with than in those without cirrhosis (14.3 ± 7.3 versus 7.20 ± 2.4, p < 0.0001). The mean fractional ECS was significantly greater in patients with cirrhosis than in those without cirrhosis (41.0% ± 9.0% versus 23.8% ± 6.3%, p < 0.0001). The fractional ECS correlated with the MELD score (r = 0.572, p < 0.0001) and was predictive of cirrhosis with an area under the receiver operating characteristic curve of 0.953 (p < 0.0001). The sensitivity and specificity of an expanded fractional ECS greater than 30% for the prediction of cirrhosis were 92% and 83%. Multivariate linear regression revealed that the fractional ECS is complementary to the MELD score as a predictor of cirrhosis (p < 0.0001). CONCLUSION. Noninvasive contrast-enhanced CT quantification of the fractional ECS correlates with the MELD score, an indicator of the severity of liver disease, and merits further study.

Original languageEnglish (US)
Pages (from-to)1204-1210
Number of pages7
JournalAmerican Journal of Roentgenology
Volume201
Issue number6
DOIs
StatePublished - Dec 1 2013
Externally publishedYes

Fingerprint

Extracellular Space
End Stage Liver Disease
Liver Diseases
Fibrosis
Liver
Aorta
Hematocrit
ROC Curve
Linear Models
Sensitivity and Specificity

Keywords

  • Cirrhosis
  • CT
  • Delayed enhancement
  • Liver

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Cite this

Contrast-enhanced CT quantification of the hepatic fractional extracellular space : Correlation with diffuse liver disease severity. / Zissen, Maurice H.; Wang, Zhen Jane; Yee, Judy; Aslam, Rizwan; Monto, Alexander; Yeh, Benjamin M.

In: American Journal of Roentgenology, Vol. 201, No. 6, 01.12.2013, p. 1204-1210.

Research output: Contribution to journalArticle

Zissen, Maurice H. ; Wang, Zhen Jane ; Yee, Judy ; Aslam, Rizwan ; Monto, Alexander ; Yeh, Benjamin M. / Contrast-enhanced CT quantification of the hepatic fractional extracellular space : Correlation with diffuse liver disease severity. In: American Journal of Roentgenology. 2013 ; Vol. 201, No. 6. pp. 1204-1210.
@article{1afb24aa7c7e4a2fae150f0f2b678427,
title = "Contrast-enhanced CT quantification of the hepatic fractional extracellular space: Correlation with diffuse liver disease severity",
abstract = "OBJECTIVE. The purpose of this study was to determine whether contrast-enhanced CT quantification of the hepatic fractional extracellular space (ECS) correlates with the severity of diffuse liver disease. MATERIALS AND METHODS. The cases of 70 patients without (46 men, 24 women; mean age, 59.1 years) and 36 patients with (23 men, 13 women; mean age, 63.1 years) cirrhosis who had undergone unenhanced and 10-minute delayed phase contrast-enhanced CT were retrospectively identified. By consensus one experienced radiologist and one trainee measured the CT attenuation of the liver and aorta to estimate the fractional ECS, defined as the ratio of the difference between the attenuation of the liver on 10-minute and unenhanced images to the difference between the attenuation of the aorta on 10-minute and unenhanced images multiplied by 1 minus the hematocrit. Findings were correlated with each patient's Model of End-Stage Liver Disease (MELD) score. RESULTS. The mean MELD score was higher in patients with than in those without cirrhosis (14.3 ± 7.3 versus 7.20 ± 2.4, p < 0.0001). The mean fractional ECS was significantly greater in patients with cirrhosis than in those without cirrhosis (41.0{\%} ± 9.0{\%} versus 23.8{\%} ± 6.3{\%}, p < 0.0001). The fractional ECS correlated with the MELD score (r = 0.572, p < 0.0001) and was predictive of cirrhosis with an area under the receiver operating characteristic curve of 0.953 (p < 0.0001). The sensitivity and specificity of an expanded fractional ECS greater than 30{\%} for the prediction of cirrhosis were 92{\%} and 83{\%}. Multivariate linear regression revealed that the fractional ECS is complementary to the MELD score as a predictor of cirrhosis (p < 0.0001). CONCLUSION. Noninvasive contrast-enhanced CT quantification of the fractional ECS correlates with the MELD score, an indicator of the severity of liver disease, and merits further study.",
keywords = "Cirrhosis, CT, Delayed enhancement, Liver",
author = "Zissen, {Maurice H.} and Wang, {Zhen Jane} and Judy Yee and Rizwan Aslam and Alexander Monto and Yeh, {Benjamin M.}",
year = "2013",
month = "12",
day = "1",
doi = "10.2214/AJR.12.10039",
language = "English (US)",
volume = "201",
pages = "1204--1210",
journal = "American Journal of Roentgenology",
issn = "0361-803X",
publisher = "American Roentgen Ray Society",
number = "6",

}

TY - JOUR

T1 - Contrast-enhanced CT quantification of the hepatic fractional extracellular space

T2 - Correlation with diffuse liver disease severity

AU - Zissen, Maurice H.

AU - Wang, Zhen Jane

AU - Yee, Judy

AU - Aslam, Rizwan

AU - Monto, Alexander

AU - Yeh, Benjamin M.

PY - 2013/12/1

Y1 - 2013/12/1

N2 - OBJECTIVE. The purpose of this study was to determine whether contrast-enhanced CT quantification of the hepatic fractional extracellular space (ECS) correlates with the severity of diffuse liver disease. MATERIALS AND METHODS. The cases of 70 patients without (46 men, 24 women; mean age, 59.1 years) and 36 patients with (23 men, 13 women; mean age, 63.1 years) cirrhosis who had undergone unenhanced and 10-minute delayed phase contrast-enhanced CT were retrospectively identified. By consensus one experienced radiologist and one trainee measured the CT attenuation of the liver and aorta to estimate the fractional ECS, defined as the ratio of the difference between the attenuation of the liver on 10-minute and unenhanced images to the difference between the attenuation of the aorta on 10-minute and unenhanced images multiplied by 1 minus the hematocrit. Findings were correlated with each patient's Model of End-Stage Liver Disease (MELD) score. RESULTS. The mean MELD score was higher in patients with than in those without cirrhosis (14.3 ± 7.3 versus 7.20 ± 2.4, p < 0.0001). The mean fractional ECS was significantly greater in patients with cirrhosis than in those without cirrhosis (41.0% ± 9.0% versus 23.8% ± 6.3%, p < 0.0001). The fractional ECS correlated with the MELD score (r = 0.572, p < 0.0001) and was predictive of cirrhosis with an area under the receiver operating characteristic curve of 0.953 (p < 0.0001). The sensitivity and specificity of an expanded fractional ECS greater than 30% for the prediction of cirrhosis were 92% and 83%. Multivariate linear regression revealed that the fractional ECS is complementary to the MELD score as a predictor of cirrhosis (p < 0.0001). CONCLUSION. Noninvasive contrast-enhanced CT quantification of the fractional ECS correlates with the MELD score, an indicator of the severity of liver disease, and merits further study.

AB - OBJECTIVE. The purpose of this study was to determine whether contrast-enhanced CT quantification of the hepatic fractional extracellular space (ECS) correlates with the severity of diffuse liver disease. MATERIALS AND METHODS. The cases of 70 patients without (46 men, 24 women; mean age, 59.1 years) and 36 patients with (23 men, 13 women; mean age, 63.1 years) cirrhosis who had undergone unenhanced and 10-minute delayed phase contrast-enhanced CT were retrospectively identified. By consensus one experienced radiologist and one trainee measured the CT attenuation of the liver and aorta to estimate the fractional ECS, defined as the ratio of the difference between the attenuation of the liver on 10-minute and unenhanced images to the difference between the attenuation of the aorta on 10-minute and unenhanced images multiplied by 1 minus the hematocrit. Findings were correlated with each patient's Model of End-Stage Liver Disease (MELD) score. RESULTS. The mean MELD score was higher in patients with than in those without cirrhosis (14.3 ± 7.3 versus 7.20 ± 2.4, p < 0.0001). The mean fractional ECS was significantly greater in patients with cirrhosis than in those without cirrhosis (41.0% ± 9.0% versus 23.8% ± 6.3%, p < 0.0001). The fractional ECS correlated with the MELD score (r = 0.572, p < 0.0001) and was predictive of cirrhosis with an area under the receiver operating characteristic curve of 0.953 (p < 0.0001). The sensitivity and specificity of an expanded fractional ECS greater than 30% for the prediction of cirrhosis were 92% and 83%. Multivariate linear regression revealed that the fractional ECS is complementary to the MELD score as a predictor of cirrhosis (p < 0.0001). CONCLUSION. Noninvasive contrast-enhanced CT quantification of the fractional ECS correlates with the MELD score, an indicator of the severity of liver disease, and merits further study.

KW - Cirrhosis

KW - CT

KW - Delayed enhancement

KW - Liver

UR - http://www.scopus.com/inward/record.url?scp=84888363362&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84888363362&partnerID=8YFLogxK

U2 - 10.2214/AJR.12.10039

DO - 10.2214/AJR.12.10039

M3 - Article

C2 - 24261358

AN - SCOPUS:84888363362

VL - 201

SP - 1204

EP - 1210

JO - American Journal of Roentgenology

JF - American Journal of Roentgenology

SN - 0361-803X

IS - 6

ER -